Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by DELLiciouson Aug 22, 2018 11:02pm
110 Views
Post# 28503494

RE:RE:yea..me neither...blueskiesahead

RE:RE:yea..me neither...blueskiesahead"You still do not get it, and it i starting to get a bit sad. Investors invest with a company that shows promise and proper execution in a growing sector." 

No, my friend, I disagree with you quite respectfully. The sad part is that you believe that there is "proper execution in a growing sector". What proper execution are we talking about when a quarterly loss by WEED was nearly $91 million "nearly double the total net loss for the entire prior financial year of $54.13 million.?" [1] Without much speculation, shouldn't proper execution result in loss reduction or even profitability? 

The fact is that WEED's reputation is such that it doesn't matter what it does or how it does it, it will be the leader. Most of the non-commercial investors know little about the market and invest into companies that show continuous growth in stock price. They don't go beyond that piece of information. They don't look at the revenues, losses, etc...zilch. That's what I've seen when talking to a number of my coworkers who invested into MJ market. APH/ACB and others do not have such reputation. I mean, imagine what Aphria's stock price would be if it reported a quartely (!!) result of such magnitude??


[1] https://www.fool.ca/2018/08/15/do-canopy-growth-corp-s-tsxweed-latest-quarterly-results-show-positive-promise/ 
Bullboard Posts